Natixis Advisors, L.P. Pfizer Inc Transaction History

Natixis Advisors, L.P.

$43.5 Billion
Q1 2024

A detailed history of Natixis Advisors, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 2,213,560 shares of PFE stock, worth $62 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,213,560

Previous 1,233,239 79.49%

Holding current value

$62 Million

Previous $35.5 Million 73.01%

% of portfolio

0.14%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $25.4 Million - $29.1 Million	980,321 Added 79.49%	2,213,560 $61.4 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $4.12 Million - $5.35 Million	-157,733 Reduced 11.34%	1,233,239 $35.5 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $34.1 Million - $39.8 Million	-1,061,722 Reduced 43.29%	1,390,972 $46.1 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $44.5 Million - $51.5 Million	1,232,948 Added 101.08%	2,452,694 $90 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $36.5 Million - $47.6 Million	-927,861 Reduced 43.2%	1,219,746 $49.8 Million

Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $34.1 Million - $44.5 Million	816,561 Added 61.35%	2,147,607 $110 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $13.9 Million - $17 Million	-317,452 Reduced 19.26%	1,331,046 $58.2 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $2.37 Million - $2.81 Million	50,997 Added 3.19%	1,648,498 $86.4 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $21.9 Million - $27.1 Million	478,224 Added 42.73%	1,597,501 $82.7 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $10.5 Million - $15.5 Million	253,047 Added 29.21%	1,119,277 $66.1 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $260,894 - $335,141	6,647 Added 0.77%	866,230 $37.3 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $2.35 Million - $2.67 Million	65,556 Added 8.26%	859,583 $33.7 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $1.66 Million - $1.87 Million	-49,574 Reduced 5.88%	794,027 $28.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $6.06 Million - $7.7 Million	-180,987 Reduced 17.66%	843,601 $31.1 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $5.17 Million - $6.06 Million	-162,700 Reduced 13.7%	1,024,588 $37.6 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $820,980 - $995,970	-27,257 Reduced 2.24%	1,187,288 $38.8 Million
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $5.38 Million - $7.69 Million	-199,145 Reduced 14.09%	1,214,545 $39.6 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $8.17 Million - $9.27 Million	248,209 Added 21.3%	1,413,690 $55.4 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $5.5 Million - $7.13 Million	-169,157 Reduced 12.67%	1,165,481 $41.9 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $848,838 - $953,050	-22,954 Reduced 1.69%	1,334,638 $57.8 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $3.78 Million - $4.16 Million	-100,855 Reduced 6.92%	1,357,592 $57.7 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $832,490 - $949,130	21,640 Added 1.51%	1,458,447 $63.7 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $4.53 Million - $5.49 Million	-131,372 Reduced 8.38%	1,436,807 $63.3 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $2.23 Million - $2.38 Million	67,738 Added 4.51%	1,568,179 $0
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $1.3 Million - $1.51 Million	40,754 Added 2.79%	1,500,441 $53.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $653,658 - $693,554	19,653 Added 1.36%	1,459,687 $52.9 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $44.6 Million - $49.2 Million	1,440,034	1,440,034 $51.4 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Pfizer Inc Transaction History